ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L02BB04 | B | Enzalutamide - 40mg | 7960 | 92314/1 | XTANDI | 40mg | 112 | Capsule, soft | Oral | Mersaco | Astellas Pharma Europe BV | The Netherlands | 259,803,920 L.L | 2.44 | E2 | Astellas Pharma Europe BV | The Netherlands | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L02BB04 | G | Enzalutamide - 40mg | 11558 | 19123/1 | ENZASTIK 40 | 40mg | 4x28 | Capsule | Oral | Droguerie Mercury S.A.L. | Eugia Pharma Specialities Limited | India | 82,838,963 L.L | 2.44 | E2 | Eugia Pharma Specialities Limited | India | 2/5/2024 | 0 |